Literature DB >> 9780096

Visual acuity and quality of life outcomes in patients with cataract in Shunyi County, China.

J Zhao1, R Sui, L Jia, A E Fletcher, L B Ellwein.   

Abstract

PURPOSE: To measure visual acuity and vision-related quality of life in individuals in rural China operated on for cataract.
METHODS: Five thousand fifty-two persons age 50 years and older, 90.9% (5,052/5,555) of a randomly selected population in Shunyi County, were examined in the fall of 1996. Visual functioning and quality of life questionnaires were administered to those with presenting visual acuity less than 6/60 in either eye and to those who were aphakic or pseudophakic.
RESULTS: Of the 87 individuals operated on for cataract, 12% (10/87) had presenting visual acuity of 6/18 or more in both eyes, and 24.1% (21/87) had less than 6/60. Twenty-five percent (29/116) of the 116 eyes operated on for cataract had presenting visual acuity of 6/18 or more, and 44.8% (52/116) had less than 6/60. Aphakic cases without glasses and uncorrectable aphakia attributable to surgical complications were common. In a multivariate regression model, including time period of surgery, hospital type, and surgical procedure, only pseudophakia was associated with better outcomes (P = .05). On a scale from 0 (maximum problems) to 100 (no problems), the mean visual functioning score (+/-SD) for the operated-on population was 61.9 +/- 30.0, and 71.0 +/- 31.8 for the quality of life questionnaire. These scores were comparable to those of the unoperated-on population with moderate bilateral blindness (<6/60 to > or =3/60 in the better eye). Visual functioning and quality of life scores were closely correlated with visual acuity in operated-on (r = 0.64 and r = 0.61, respectively) and unoperated-on populations (r = 0.68 and r = 0.59, respectively).
CONCLUSIONS: Both clinical and patient-reported cataract surgery outcomes are below what should be achievable. Improvement in outcomes must be given greater emphasis if the potential of cataract surgery in restoring sight is to be realized.

Entities:  

Mesh:

Year:  1998        PMID: 9780096     DOI: 10.1016/s0002-9394(98)00274-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  37 in total

1.  Cataract surgery in very elderly patients. Biological age is more important than chronological age.

Authors:  N Beare
Journal:  BMJ       Date:  2001-08-25

2.  Outcomes of extracapsular surgery in eye camps of eastern Nepal.

Authors:  J K Shrestha; Y M Pradhan; T Snellingen
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

3.  Assessment of visual gain following cataract surgeries in oman: a hospital-based cohort study.

Authors:  Rajiv Khandekar; Abdulatif Al Raisi
Journal:  Oman Med J       Date:  2009-01

4.  Routine monitoring of visual outcome of cataract surgery. Part 1: Development of an instrument.

Authors:  H Limburg; A Foster; C Gilbert; G J Johnson; M Kyndt
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

5.  Cataract surgical coverage and outcome in the Tibet Autonomous Region of China.

Authors:  K L Bassett; K Noertjojo; L Liu; F S Wang; C Tenzing; A Wilkie; M Santangelo; P Courtright
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

6.  Monitoring cataract surgical outcomes: methods and tools.

Authors:  Hans Limburg
Journal:  Community Eye Health       Date:  2002

7.  What do we mean by cataract outcomes?

Authors:  L Dandona; H Limburg
Journal:  Community Eye Health       Date:  2000

8.  Monitoring cataract surgical outcomes: computerised systems.

Authors:  David Yorston
Journal:  Community Eye Health       Date:  2002

9.  Visual acuity and quality of life outcomes in cataract surgery patients in Hong Kong.

Authors:  Joseph Lau; John J Michon; Wing-Shing Chan; Leon B Ellwein
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

Review 10.  The surgical management of cataract: barriers, best practices and outcomes.

Authors:  Margaret A Chang; Nathan G Congdon; Shawn K Baker; Martin W Bloem; Howard Savage; Alfred Sommer
Journal:  Int Ophthalmol       Date:  2007-08-22       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.